Try our Advanced Search for more refined results
Macleods Pharmaceuticals Ltd.
-
Order | Filed: May 31, 2024 In re: Entresto (Sacubitril/Valsartan) Patent Litigation
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Order
MEMORANDUM OPINION regarding claim construction of one term in U.S. Patent No. 11,096,918 (see Memorandum Opinion for further details). Signed by Judge Richard G. Andrews on 5/31/2024. Associated Cases: 1:20-md-02930-RGA, 1:22-cv-01395-RGA(nms)
-
Order | Filed: May 29, 2024 | Entered: May 29, 2024 In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
Patent - Abbreviated New Drug Application(ANDA) | Delaware
SO ORDERED
SO ORDERED, re (D.I. 16 in 23-cv-1219-RGA; D.I. 271 in 21-md-3017-RGA-LDH) STIPULATION and Proposed Order to Extend Time to answer, move or otherwise respond to the Complaint to June 28, 2024. Signed by Judge Richard G. Andrews on 5/29/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01219-RGA(nms)
-
Motion | Filed: May 29, 2024 | Entered: May 29, 2024 In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Stipulation to EXTEND Time
STIPULATION TO EXTEND TIME for Defendants to answer, move or otherwise respond to the Complaint to June 28, 2024 - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login